1) cycloheximide
亚胺环已酮
1.
Mouse eggs(18～19 h post-hCG)can be efficiently activated by treatment with ethanol-cycloheximide,and the activation rate for that was similar with that of ethanol eontral gro.
蛋白合成抑制剂亚胺环已酮不能抑制小鼠卵泡卵母细胞体外培养过程中自发的生发泡破裂(GVBD),但可抑制卵母细胞第一极体的释放。
2) imino
亚胺
1.
The fluorene derivatives containing imino groups,N-(2,7-dibromo-9-fluorenylidene)aniline(NBFA),4-chloro-N-(2,7-dibromo-9-fluorenylidene)aniline(CNBFA) and N-(2,7-dibromo-9-fluorenylidene)-4-methylaniline(NBFMA) as novel luminescent compounds were synthesized by the reaction of 2,7-dibromofluorenone and corresponding aniline derivatives.
通过2,7-二溴芴酮与相应的苯胺衍生物反应,合成了一系列新型的连有亚胺基的芴类衍生物:2,7-二溴-9-亚苯胺基芴(NBFA),2,7-二溴-9-亚(4-氯-苯胺)基芴(CNBFA),2,7-二溴-9-亚(4-甲基-苯胺)基芴(NBFMA),其结构经核磁共振谱、红外光谱和质谱表征。
3) Imine
亚胺
1.
Synthesis and Biological Activity of Novel Imine Derivatives Containing Triazole and Thiazole Ring;
新型含噻唑和三唑环的亚胺类化合物的合成及生物活性研究
2.
Application of chiral nitrogen-containing ligands in asymmetric addition to imines with organolithium reagents;
手性含氮配体在有机锂试剂对亚胺不对称加成反应中的应用进展
3.
Effect of Microwave Irradiation on the Syn/Trans Selectivity in the Formation of β-Lactams From Ketenes and Imines;
微波对烯酮和亚胺形成β-内酰胺顺反选择性的影响
4) imines
亚胺
1.
Recent advances in addition,reduction,and asymmetric reactions of imines were reviewed.
亚胺是一类羰基化合物(醛或酮)与氨(胺)的缩合产物,作者综述了近年国内外亚胺在加成、还原和不对称反应等方面的研究进展。
2.
The recent progress in the asymmetric aziridination of prochiral olefines and imines espeically with emphasis on the chiral catalysts and nitrogen or carbon transfer reagents during last two decades is summarized in this review.
本文综述了近 2 0年来从潜手性烯烃和亚胺出发不对称催化氮杂环丙烷化反应的研究进展 ,重点评述了手性配体及氮转移试剂 (或碳转移试剂 )的研
3.
This review covers the recent advances on the asymmetric addition reactions of alkylzinc reagents with imines.
综述了烷基锌与亚胺不对称加成反应的最新进展。
5) Schiff’s bases
亚胺
6) azomethine imines
甲亚胺亚胺
参考词条
补充资料：丙二胺亚胺,丙二胺四乙酰亚胺
分子式：
CAS号：
性质：又名丙二胺亚胺，丙二胺四乙酰亚胺，抗癌-173。为白色粉末，溶于热水，酸中稳定，碱中不稳定。由哌嗪二酮制取。适用于急性白血病、恶性淋巴瘤、肺癌、肝癌、胃癌、肾癌和软组织肉瘤术后预防远处转移，特别是肺转移的发生。制剂为片剂。
CAS号：
性质：又名丙二胺亚胺，丙二胺四乙酰亚胺，抗癌-173。为白色粉末，溶于热水，酸中稳定，碱中不稳定。由哌嗪二酮制取。适用于急性白血病、恶性淋巴瘤、肺癌、肝癌、胃癌、肾癌和软组织肉瘤术后预防远处转移，特别是肺转移的发生。制剂为片剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。